Compound information
- Natural Products
- ZC2146607
- Molecular Formula
- C18H19ClFN3O
- Molecular Weight
- 347.120068128 g/mol
- Structure
-
- IUPAC Name
- N-(4-chlorophenyl)-4-[(3-fluorophenyl)methyl]piperazine-1-carboxamide
- InChI
- InChI=1S/C18H19ClFN3O/c19-15-4-6-17(7-5-15)21-18(24)23-10-8-22(9-11-23)13-14-2-1-3-16(20)12-14/h1-7,12H,8-11,13H2,(H,21,24)
- InChI Key
- VWILGDKYOWUEGP-UHFFFAOYSA-N
- SMILES
- O=C(Nc1ccc(Cl)cc1)N1CCN(Cc2cccc(F)c2)CC1
- Source
- ZINC000020437762
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 35.58 Å2 | LogP | 3.681 |
LogS | -3.914 | LogD | 4.052 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.996 | Pgp substrate | 0.867 |
HIA | 0.969 | F20 % | 0.991 |
F30 % | 0.982 | Caco-2 | -4.749 |
MDCK | -4.87 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.662 | PPB | 97.574 |
VD | 2.016 | Fu | 1.277 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.061 | CYP1A2 substrate | 0.802 |
CYP2A6 substrate | 0.84 | CYP2B6 substrate | 0.661 |
CYP2C19 inhibitor | 0.966 | CYP2C19 substrate | 0.954 |
CYP2C8 substrate | 0.935 | CYP2C9 inhibitor | 0.653 |
CYP2C9 substrate | 0.898 | CYP2D6 inhibitor | 0.983 |
CYP2D6 substrate | 0.996 | CYP2E1 substrate | 0.937 |
CYP3A4 inhibitor | 0.175 | CYP3A4 substrate | 0.991 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.178 | CL | 9.937 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.998 | Hepatotoxicity | 0.966 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.785 |
FDAMDD | 0.57 | Skin Sensitization | 0.822 |
Carcinogenicity | 0.06 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.854 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.727 | IGC50 | 3.525 |
LC50FM | 1.574 | LC50DM | -1.114 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.389 | NR-AR-LBD | 0.194 |
NR-AhR | 0.696 | NR-Aromatase | 0.033 |
NR-ER | 0.354 | NR-ER-LBD | 0.305 |
NR-PPAR-gamma | 0.192 | SR-ARE | 0.878 |
SR-ATAD5 | 0.343 | SR-HSE | 0.11 |
SR-MMP | 0.072 | SR-p53 | 0.105 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.